Controlled Release of Enzyme TrxR1 Can Help Treat 60 Types of Cancer

by Julia Samuel on  February 16, 2018 at 12:51 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

Molecules that control the release of a selenium-containing enzyme in the human body may become a tool to fight cancer.

Scientists effectively treated over 60 different types of cancer cells under laboratory conditions with these molecules.
Controlled Release of Enzyme TrxR1 Can Help Treat 60 Types of Cancer
Controlled Release of Enzyme TrxR1 Can Help Treat 60 Types of Cancer

The study published in the US medical journal Science Translational Medicine said researchers at Karolinska Institute in Sweden treated cancer in mice with these molecules and observed rapid tumor-killing effects.

Show Full Article


They have expressed hope that this new principle could be extended to treat cancer in humans, Xinhua news agency reported.

Selenium is a chemical element that is an essential micronutrient. A selenium-containing enzyme, called TrxR1, can be used to support the growth of various cells and protect them from oxidative stress.

Oxidative stress is the imbalance between the production of free radicals, which are highly reactive with other molecules, and the body's ability to counteract or to repair the resulting damage.

However, in several forms of cancer, raised levels of TrxR1 could be detected.

Researchers analyzed almost 400,000 different molecules to find new ones that would more specifically control TrxR1 and found three different types which proved to be active as anti-cancer medicines.

"This effectiveness against cancer may be a result of cancer cells' seemingly greater sensitivity to oxidative stress when compared to normal cells, which in turn can be utilized in cancer therapy," Elias Arner, a professor at the Karolinska Institute, who led the study, said.

"This seems to work in mouse models and we are therefore hopeful that this principle of treatment can be developed for humans, even if this will require many years of further research," he added.

Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive